Myocardial Gene Expression in Heart Failure Patients Treated With Cardiac Resynchronization Therapy. Responders Versus Nonresponders

Journal of the American College of Cardiology

Volumn 51, Issue 2, 2008, Pages 129-136

  Vanderheyden, Marc ^a   Mullens, Wilfried ^a   Delrue, Leen ^a   Goethals, Marc ^a   de Bruyne, Bernard ^a   Wijns, William ^a   Geelen, Peter ^a   Verstreken, Sofie ^a   Wellens, Francis ^a   Bartunek, Jozef ^a  

^a CARDIOVASCULAR CENTER   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; MESSENGER RNA; SPIRONOLACTONE;

ADULT; AGED; ARTICLE; ARTIFICIAL HEART PACEMAKER; CARDIAC RESYNCHRONIZATION THERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; DOPPLER ECHOCARDIOGRAPHY; FEMALE; GENE EXPRESSION; GENETIC REGULATION; HEART FAILURE; HEART FUNCTION; HEART MUSCLE BIOPSY; HEMODYNAMICS; HUMAN; MALE; MUSCLE CONTRACTILITY; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SARCOPLASMIC RETICULUM;

AGED; CARDIAC PACING, ARTIFICIAL; CASE-CONTROL STUDIES; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETIC MARKERS; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; MYOCARDIUM; MYOSIN HEAVY CHAINS; NATRIURETIC PEPTIDE, BRAIN; PROBABILITY; PROGNOSIS; REFERENCE VALUES; RISK ASSESSMENT; RNA, MESSENGER; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC; SURVIVAL RATE; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 37849013369     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2007.07.087     Document Type: Article

References (37)

1. Bouvagnet P., Leger J., Dechesne C.A., Dureau G., Anoal M., and Leger J.J. Local changes in myosin types in diseased human atrial myocardium: a quantitative immunofluorescence study. Circulation 72 (1985) 272-279
2. Mercadier J.J., de la Bastie D., Menasche P., et al. Alpha-myosin heavy chain isoform and atrial size in patients with various types of mitral valve dysfunction: a quantitative study. J Am Coll Cardiol 9 (1987) 1024-1030
3. Tsuchimochi H., Sugi M., Kuro-o M., et al. Isozymic changes in myosin of human atrial myocardium induced by overload. Immunohistochemical study using monoclonal antibodies. J Clin Invest 74 (1984) 662-665
4. Hasenfuss G., Reinecke H., Studer R., et al. Relation between myocardial function and expression of sarcoplasmic reticulum Ca(2+)-ATPase in failing and nonfailing human myocardium. Circ Res 75 (1994) 434-442
5. Olson E.N. A decade of discoveries in cardiac biology. Nat Med 10 (2004) 467-474
6. Heerdt P.M., Holmes J.W., Cai B., et al. Chronic unloading by left ventricular assist device reverses contractile dysfunction and alters gene expression in end-stage heart failure. Circulation 102 (2000) 2713-2719
7. Liang H., Muller J., Weng Y.G., et al. Changes in myocardial collagen content before and after left ventricular assist device application in dilated cardiomyopathy. Chin Med J (Engl) 117 (2004) 401-407
8. Dipla K., Mattiello J.A., Jeevanandam V., Houser S.R., and Margulies K.B. Myocyte recovery after mechanical circulatory support in humans with end-stage heart failure. Circulation 97 (1998) 2316-2322
9. Takeishi Y., Jalili T., Hoit B.D., et al. Alterations in Ca2+ cycling proteins and G alpha q signaling after left ventricular assist device support in failing human hearts. Cardiovasc Res 45 (2000) 883-888
10. Lowes B.D., Gilbert E.M., Abraham W.T., et al. Myocardial gene expression in dilated cardiomyopathy treated with beta-blocking agents. N Engl J Med 346 (2002) 1357-1365
11. Nelson G.S., Berger R.D., Fetics B.J., et al. Left ventricular or biventricular pacing improves cardiac function at diminished energy cost in patients with dilated cardiomyopathy and left bundle-branch block. Circulation 102 (2000) 3053-3059
12. Molhoek S.G., Bax J.J., Bleeker G.B., et al. Long-term follow-up of cardiac resynchronization therapy in patients with end-stage heart failure. J Cardiovasc Electrophysiol 16 (2005) 701-707
13. Cleland J.G., Thackray S., Goodge L., Kaye G., and Cooklin M. Outcome studies with device therapy in patients with heart failure. J Cardiovasc Electrophysiol 13 (2002) S73-S91
14. Linde C., Leclercq C., Rex S., et al. Long-term benefits of biventricular pacing in congestive heart failure: results from the MUltisite STimulation in cardiomyopathy (MUSTIC) study. J Am Coll Cardiol 40 (2002) 111-118
15. Penicka M., Bartunek J., De Bruyne B., et al. Improvement of left ventricular function after cardiac resynchronization therapy is predicted by tissue Doppler imaging echocardiography. Circulation 109 (2004) 978-983
16. Daubert J.C., Ritter P., Le Breton H., et al. Permanent left ventricular pacing with transvenous leads inserted into the coronary veins. Pacing Clin Electrophysiol 21 (1998) 239-245
17. Vanderheyden M., De Backer T., Rivero-Ayerza M., et al. Tailored echocardiographic interventricular delay programming further optimizes left ventricular performance after cardiac resynchronization therapy. Heart Rhythm 2 (2005) 1066-1072
18. Thomas J.D. How leaky is that mitral valve?. Simplified Doppler methods to measure regurgitant orifice area. Circulation 95 (1997) 548-550
19. Lang R.M., Bierig M., Devereux R.B., et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 18 (2005) 1440-1463
20. Bax J.J., Bleeker G.B., Marwick T.H., et al. Left ventricular dyssynchrony predicts response and prognosis after cardiac resynchronization therapy. J Am Coll Cardiol 44 (2004) 1834-1840
21. Lowes B.D., Minobe W., Abraham W.T., et al. Changes in gene expression in the intact human heart. Downregulation of alpha-myosin heavy chain in hypertrophied, failing ventricular myocardium. J Clin Invest 100 (1997) 2315-2324
22. Bristow M.R. Why does the myocardium fail?. Insights from basic science. Lancet 352 Suppl 1 (1998) SI8-SI14
23. Holubarsch C., Hasenfuss G., Thierfelder L., Pieske B., and Just H. The heart in heart failure. Ventricular and myocardial alterations. Eur Heart J 12 Suppl C (1991) 8-13
24. Fitzsimons D.P., Patel J.R., and Moss R.L. Role of myosin heavy chain composition in kinetics of force development and relaxation in rat myocardium. J Physiol 513 (1998) 171-183
25. Herron T.J., Korte F.S., and McDonald K.S. Loaded shortening and power output in cardiac myocytes are dependent on myosin heavy chain isoform expression. Am J Physiol Heart Circ Physiol 281 (2001) H1217-H1222
26. Hajjar R.J., Huq F., Matsui T., and Rosenzweig A. Genetic editing of dysfunctional myocardium. Med Clin North Am 87 (2003) 553-567
27. del Monte F., Harding S.E., Dec G.W., Gwathmey J.K., and Hajjar R.J. Targeting phospholamban by gene transfer in human heart failure. Circulation 105 (2002) 904-907
28. Muller O.J., Lange M., Rattunde H., et al. Transgenic rat hearts overexpressing SERCA2a show improved contractility under baseline conditions and pressure overload. Cardiovasc Res 59 (2003) 380-389
29. Meyer M., Schillinger W., Pieske B., et al. Alterations of sarcoplasmic reticulum proteins in failing human dilated cardiomyopathy. Circulation 92 (1995) 778-784
30. Abraham W.T., Fisher W.G., Smith A.L., et al. Cardiac resynchronization in chronic heart failure. N Engl J Med 346 (2002) 1845-1853
31. Kogler H., Schott P., Toischer K., et al. Relevance of brain natriuretic peptide in preload-dependent regulation of cardiac sarcoplasmic reticulum Ca2+ ATPase expression. Circulation 113 (2006) 2724-2732
32. Spragg D.D., Leclercq C., Loghmani M., et al. Regional alterations in protein expression in the dyssynchronous failing heart. Circulation 108 (2003) 929-932
33. Prestle J., Dieterich S., Preuss M., Bieligk U., and Hasenfuss G. Heterogeneous transmural gene expression of calcium-handling proteins and natriuretic peptides in the failing human heart. Cardiovasc Res 43 (1999) 323-331
34. Linck B., Boknik P., Baba H.A., et al. Long-term beta adrenoceptormediated alteration in contractility and expression of phospholamban and sarcoplasmic reticulum Ca++-ATPase in mammalian ventricle. J Pharmacol Exp Ther 286 (1998) 531-538
35. Boluyt M.O., Long X., Eschenhagen T., et al. Isoproterenol infusion induces alterations in expression of hypertrophy-associated genes in rat heart. Am J Physiol 269 (1995) H638-H647
36. Najem B., Unger P., Preumont N., et al. Sympathetic control after cardiac resynchronization therapy: responders versus nonresponders. Am J Physiol Heart Circ Physiol 291 (2006) H2647-H2652
37. Eiken H.G., Oie E., Damas J.K., et al. Myocardial gene expression of leukaemia inhibitory factor, interleukin-6 and glycoprotein 130 in end-stage human heart failure. Eur J Clin Invest 31 (2001) 389-397